Correlation Between Inhibrx and Abcellera Biologics

Can any of the company-specific risk be diversified away by investing in both Inhibrx and Abcellera Biologics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Inhibrx and Abcellera Biologics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Inhibrx and Abcellera Biologics, you can compare the effects of market volatilities on Inhibrx and Abcellera Biologics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Inhibrx with a short position of Abcellera Biologics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Inhibrx and Abcellera Biologics.

Diversification Opportunities for Inhibrx and Abcellera Biologics

0.18

Correlation Coefficient

Inhibrx  Abcellera Biologics

Average diversification

The 3 months correlation between Inhibrx and Abcellera is 0.18. Overlapping area represents the amount of risk that can be diversified away by holding Inhibrx and Abcellera Biologics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Abcellera Biologics and Inhibrx is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Inhibrx are associated (or correlated) with Abcellera Biologics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Abcellera Biologics has no effect on the direction of Inhibrx i.e., Inhibrx and Abcellera Biologics go up and down completely randomly.

Pair Corralation between Inhibrx and Abcellera Biologics

Given the investment horizon of 90 days Inhibrx is expected to under-perform the Abcellera Biologics. But the stock apears to be less risky and, when comparing its historical volatility, Inhibrx is 1.31 times less risky than Abcellera Biologics. The stock trades about -0.01 of its potential returns per unit of risk. The Abcellera Biologics is currently generating about 0.1 of returns per unit of risk over similar time horizon. If you would invest  250.00  in Abcellera Biologics on September 3, 2024 and sell it today you would earn a total of  53.00  from holding Abcellera Biologics or generate 21.2% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Inhibrx  vs.  Abcellera Biologics

Inhibrx

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Inhibrx has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong fundamental drivers, Inhibrx is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.

Abcellera Biologics

Risk-Adjusted Performance

7 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Abcellera Biologics are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite quite weak fundamental indicators, Abcellera Biologics disclosed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Inhibrx and Abcellera Biologics

The main advantage of trading using opposite Inhibrx and Abcellera Biologics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Inhibrx position performs unexpectedly, Abcellera Biologics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Abcellera Biologics will offset losses from the drop in Abcellera Biologics' long position.

The idea behind Inhibrx and Abcellera Biologics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.